Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$679K Buy
9,235
+514
+6% +$37.9K 0.24% 67
2020
Q4
$681K Sell
8,721
-1,793
-17% -$137K 0.24% 60
2020
Q3
$832K Buy
10,514
+3,594
+52% +$282K 0.38% 39
2020
Q2
$511K Buy
+6,920
New +$521K 0.24% 60
2019
Q3
Sell
-7,318
Closed -$586K 394
2019
Q2
$586K Buy
+7,318
New +$560K 0.26% 75

Other funds holding MRK

WealthStone's MRK Position: Q1 2021 in Review

WealthStone increased its Merck (MRK) stake by 5.9% in Q1 2021, buying an estimated $37.9K and bringing the position to 9,235 shares worth $679K. The position accounts for 0.24% of the portfolio, ranked #67.

WealthStone first reported a position in MRK in Q2 2019 and has held it in 5 quarters since. The position peaked at $832K in Q3 2020. 2,686 funds tracked by Wall St. Rank hold MRK as of Q1 2021.

  • WealthStone held 9,235 shares of Merck worth $679K as of Q1 2021.
  • WealthStone bought 514 Merck shares in Q1 2021, an estimated $37.9K.
  • Merck made up 0.24% of WealthStone's portfolio in Q1 2021, its #67 holding.
  • WealthStone first reported a position in Merck in Q2 2019 and has held it in 5 quarters since.
  • WealthStone's Merck position peaked at $832K in Q3 2020.
  • 2,686 funds tracked by Wall St. Rank held Merck as of Q1 2021.

Based on WealthStone's 13F filing for Q1 2021, filed 13 May 2021.